Drug Trial Radar · NCT05267821
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
Last checked: Nov 20, 2026Latest source record: Mar 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Jun 14, 2022
Primary completion
May 15, 2028
Study completion Aug 31, 2028
Sponsor
- Lead sponsor
- Nationwide Children's HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- First posted
- Mar 4, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 1 day, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The TRIPS study is a prospective, multi-center, double-blind, adaptively randomized, placebo-controlled clinical trial of the drug anakinra for reversal of moderate to severe hyperinflammation in children with sepsis-induced multiple organ dysfunction syndrome (MODS).
Conditions
- Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS)
Interventions
AnakinraDrug
See information in arm/group descriptions
PlaceboDrug
See information in arm/group descriptions
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cumulative 28-day Pediatric Logistic Organ Dysfunction (PELOD-2) scoreTime frame: 28 days from randomization
Locations
32 sites in 1 country. Site status is shown where the registry gives one.
Children's of Alabama
Birmingham, Alabama · Recruiting
Arkansas Children's Hospital
Little Rock, Arkansas · Recruiting
Children's Hospital of Los Angeles
Los Angeles, California · Recruiting
Benioff Children's Hospital - Oakland
Oakland, California · Recruiting
Children's Hospital of Orange County
Orange, California · Not yet recruiting
University of California, Davis
Sacramento, California · Recruiting
Rady Children's Hospital
San Diego, California · Recruiting
Benioff Children's Hospital - Mission Bay
San Francisco, California · Recruiting
Children's Hospital Colorado
Aurora, Colorado · Recruiting
Children's National Medical Center
Washington D.C., District of Columbia · Recruiting
Children's Hospital of Atlanta
Atlanta, Georgia · Recruiting
Riley Children's Hospital
Indianapolis, Indiana · Recruiting
CS Mott Children's Hospital
Ann Arbor, Michigan · Recruiting
Children's Hospital of Michigan
Detroit, Michigan · Recruiting
Children's Hospital of Minnesota
Minneapolis, Minnesota · Not yet recruiting
University of Minnesota
Minneapolis, Minnesota · Recruiting
Mercy Children's Hospital
Kansas City, Missouri · Recruiting
Duke University
Durham, North Carolina · Recruiting
Akron Children's Hospital
Akron, Ohio · Recruiting
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio · Recruiting
Rainbow Babies and Children's Hospital
Cleveland, Ohio · Recruiting
Nationwide Children's Hospital
Columbus, Ohio · Recruiting
Pennsylvania State University
Hershey, Pennsylvania · Recruiting
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania · Recruiting
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania · Recruiting
Medical University of South Carolina
Charleston, South Carolina · Recruiting
University of Texas Southwestern
Dallas, Texas · Recruiting
Texas Children's Hospital
Houston, Texas · Recruiting
Children's Hospital of San Antonio
San Antonio, Texas · Recruiting
Primary Children's Hospital
Salt Lake City, Utah · Recruiting
Virginia Commonwealth University
Richmond, Virginia · Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.